These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16737760)

  • 21. Design and synthesis of an alpha1a-adrenergic receptor subtype-selective antagonist from BE2254.
    Chiu G; Gluchowski C; Forray C
    Chem Biol Drug Des; 2006 Jun; 67(6):437-9. PubMed ID: 16882319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha(1) adrenoceptor subtype selectivity. 3D-QSAR models for a new class of alpha(1) adrenoceptor antagonists derived from the novel antipsychotic sertindole.
    Balle T; Andersen K; Søby KK; Liljefors T
    J Mol Graph Model; 2003 Jun; 21(6):523-34. PubMed ID: 12676239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of selective alpha1B adrenoceptor antagonists.
    Hayashi R; Ohmori E; Isogaya M; Moriwaki M; Kumagai H
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4045-7. PubMed ID: 16723224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of new piperazine-pyridazinone derivatives and their binding affinity toward alpha1-, alpha2-adrenergic and 5-HT1A serotoninergic receptors.
    Betti L; Zanelli M; Giannaccini G; Manetti F; Schenone S; Strappaghetti G
    Bioorg Med Chem; 2006 Apr; 14(8):2828-36. PubMed ID: 16376083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isoxazolo-[3,4-d]-pyridazin-7-(6H)-ones and their corresponding 4,5-disubstituted-3-(2H)-pyridazinone analogues as new substrates for alpha1-adrenoceptor selective antagonists: synthesis, modeling, and binding studies.
    Montesano F; Barlocco D; Dal Piaz V; Leonardi A; Poggesi E; Fanelli F; De Benedetti PG
    Bioorg Med Chem; 1998 Jul; 6(7):925-35. PubMed ID: 9730228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel α1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and α1d computational study.
    Carrieri A; Piergentili A; Del Bello F; Giannella M; Pigini M; Leonardi A; Fanelli F; Quaglia W
    Bioorg Med Chem; 2010 Oct; 18(19):7065-77. PubMed ID: 20801662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationship study on alpha1 adrenergic receptor antagonists from beer.
    Wakimoto T; Nitta M; Kasahara K; Chiba T; Ye Y; Tsuji K; Kan T; Nukaya H; Ishiguro M; Koike M; Yokoo Y; Suwa Y
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5905-8. PubMed ID: 19762239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, crystal structure, biological evaluation and molecular docking studies of carbazole-arylpiperazine derivatives.
    Xu W; Huang J; Shao B; Xu X; Jiang R; Yuan M
    Bioorg Med Chem; 2016 Nov; 24(21):5565-5572. PubMed ID: 27663545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative structure-activity relationship study of iodinated analogues of trimetoquinol as highly potent beta 2-adrenoceptor ligands.
    Kumar R; Singh P
    Indian J Biochem Biophys; 1998 Dec; 35(6):390-2. PubMed ID: 10412236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha1- and alpha2-adrenoreceptor antagonist profiles of 1- and 2-[omega-(4-arylpiperazin-1-yl)alkyl]-1,2,3-benzotriazoles.
    Boido A; Budriesi R; Boido CC; Ioan P; Terranova E; Chiarini A; Sparatore F
    Chem Biodivers; 2005 Oct; 2(10):1290-304. PubMed ID: 17191929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT
    Del Bello F; Bonifazi A; Giannella M; Giorgioni G; Piergentili A; Petrelli R; Cifani C; Micioni Di Bonaventura MV; Keck TM; Mazzolari A; Vistoli G; Cilia A; Poggesi E; Matucci R; Quaglia W
    Eur J Med Chem; 2017 Jan; 125():233-244. PubMed ID: 27662034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacophore-based design, synthesis, biological evaluation, and 3D-QSAR studies of aryl-piperazines as alpha(1)-adrenoceptor antagonists.
    Li MY; Fang H; Xia L
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3216-9. PubMed ID: 15935663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model.
    Tuccinardi T; Schenone S; Bondavalli F; Brullo C; Bruno O; Mosti L; Zizzari AT; Tintori C; Manetti F; Ciampi O; Trincavelli ML; Martini C; Martinelli A; Botta M
    ChemMedChem; 2008 Jun; 3(6):898-913. PubMed ID: 18338422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioisosteric phentolamine analogs as potent alpha-adrenergic antagonists.
    Hong SS; Bavadekar SA; Lee SI; Patil PN; Lalchandani SG; Feller DR; Miller DD
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4691-5. PubMed ID: 16153828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity.
    Giardinà D; Martarelli D; Sagratini G; Angeli P; Ballinari D; Gulini U; Melchiorre C; Poggesi E; Pompei P
    J Med Chem; 2009 Aug; 52(15):4951-4. PubMed ID: 19719240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligand design and synthesis of new imidazo[5,1-b]quinazoline derivatives as alpha1-adrenoceptor agonists and antagonists.
    Ismail MA; Aboul-Enein MN; Abouzid KA; Serya RA
    Bioorg Med Chem; 2006 Feb; 14(4):898-910. PubMed ID: 16337797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The preparation of HEK293 alpha1A or HEK293 alpha1B cell membrane stationary phase and the chromatographic affinity study of ligands of alpha1 adrenoceptor.
    Yu W; Yuan B; Deng X; He L; Youyi Z; Qide H
    Anal Biochem; 2005 Apr; 339(2):198-205. PubMed ID: 15797559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational study of antagonist/alpha1A adrenoceptor complexes--observations of conformational variations on the formation of ligand/receptor complexes.
    Kinsella GK; Rozas I; Watson GW
    J Med Chem; 2006 Jan; 49(2):501-10. PubMed ID: 16420037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Internalization and distribution of three alpha1-adrenoceptor subtypes in HEK293A cells before and after agonist stimulation.
    Wang SY; Song Y; Xu M; He QH; Han QD; Zhang YY
    Acta Pharmacol Sin; 2007 Mar; 28(3):359-66. PubMed ID: 17302998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.